Medical Oncology » Physicians

• Language: English
• College: Achimota School Sixth Form College
• Medical School: University of Chana Medical School
• Internship: Agnes Hospital
• Residency: St. Agnes Hospital
• Fellowship: University of Maryland School of Medicine Greenbaum Cancer Center
• Board Certification: American Board of Internal Medicine: Hematology, Medical Oncology, Internal Medicine

Dr. Clarence Adoo specializes in hematology, oncology and internal medicine.

Dr. Adoo joined Arizona Center for Cancer Care in 2008. He received his undergraduate degree from Achimota School Sixth Form College in Ghana. He earned his medical degree from the University of Ghana Medical School. Dr. Adoo completed his internship and residency at the St. Agnes Hospital, where he would eventually serve as the chief resident. He completed a fellowship at the University of Maryland School of Medicine’s Greenbaum Cancer Center.

Dr. Adoo has been or is currently a member of the American College of Physicians/American Society of Internal Medicine, American Association of Blood Banks, American Society of Hematology and American Society of Clinical Oncologists amongst others.

Dr. Adoo has publications in several journals and authored many chapters in books, including Acute Myeloid Leukemia, Alternative Management Strategies in Alloimmunized Thrombocytopenic Patients, Infection in the Neutropenic Host, Management of infection in Oncology Patients and Adult Leukemia: American Cancer Society Atlas. In addition to his published work, Dr. Adoo has participated in several presentations at the Hematology Oncology Fellowship Program, National Institute of Health, Leukemia and Lymphoma Society/Cure for Lymphoma Association and Phoenix Veterans Affairs Hospital.

He has been honored as a fellow by the American College of Physicians and lauded by America’s Registry of Outstanding Professionals, among other honors.

• Language(s): English and Korean

• College: Case Western Reserve University
• Medical School: Wright State University School of Medicine
• Residency: Loyola University Medical Center
• Fellowship: University of Arizona Medical Center
• Board Certification: American Board of Internal Medicine, Medical Oncology, Internal Medicine

Dr. James Choi specializes in hematology, medical oncology and internal medicine.

Dr. Choi joined Arizona Center for Cancer Care in October 2008. He received his Bachelor degree in Biochemistry at Case Western Reserve University. He completed medical school at Wright State University School of Medicine, his medical residency at Loyola University Medical Center and fellowship at the University of Arizona Medical Center where he was the chief fellow.

Dr. Choi has participated in a number of research studies involving role of U5 in mRNA splicing complex, second allogeneic transplant for relapsed high-grad hematologic malignancies, radiation therapy for gastroesophageal junction and gastric carcinoma as well as transcriptosome profiling of B-CLL to identify novel markers for prognosis and therapeutic targets.

In addition to his research, Dr. Choi has been published in the Journal of Bone Marrow Transplant and has presented his research findings at the American Society of Hematology
Annual Meeting.

• Language(s): English, Spanish and French

• Medical School: University of Western Ontario
• Internship: McGill University
• Residency: Dalhousie University
• Fellowship: McMaster University
• Board Certification: American Board of Internal Medicine, Hematology, Internal Medicine

Dr. Joan Dahmer specializes in hematology, medical oncology and internal medicine.

Dr. Dahmer joined Arizona Center for Cancer Care in 2008 when her team at Arizona Center for Hematology and Oncology partnered with the practice. She completed medical school at University of Western Ontario after being admitted on a faculty scholarship just one year out of high school. Dr. Dahmer completed her internship at McGill University in Montreal and her fellowship at McMaster University in Hamilton (Canada). In addition, Dr. Dahmer completed her residency at Dalhousie University, where she also served as chief resident. Prior to joining Arizona Center for Hematology and Oncology in 2002, Dr. Dahmer developed the oncology program at both Maryvale and Memorial Hospitals in Phoenix. She was also Chief of Medicine at Laurentian Hospital in California and has served as a medical consultant for prominent centers and labs.

Dr. Dahmer has been active in the medical community as a past or current member of several organizations, most recently as a member of The Arizona Clinical Oncology Society, the

American Society of Hematology and the Association of Community Cancer Centers, just to name a few. She has also volunteered her time to many health-related causes, including serving as medical director for the HAVEN Program of Northeastern Ohio, a comprehensive program for those infected with and affected by HIV.

She has presented on a number of topics including, medical marijuana, cardiac assessment in home care to home health nurses, women in medicine, oral & lung cancer and medicine as a career.

Dr. Dahmer is certified by the American Board of Medical Oncology, American Board of Internal Medicine.

• Language(s): English

• College: University of Nebraska
• Medical School: University of Nebraska
• Internship: University of Nebraska
• Residency: University of Nebraska and Michigan State University
• Fellowship: University of California, San Francisco
• Board Certification: American Board of Internal Medicine, Medical Oncology, Internal Medicine

Specializing in medical oncology, hematology and internal medicine, Dr. Donovan joined Arizona Center for Cancer Care in 2013, when his team at Scottsdale Cancer Center partnered with the practice. He earned his bachelor of science degree from the University of Nebraska and completed medical school and a residency in internal medicine at the University of Nebraska Medical Center. He completed an internship in internal medicine at Michigan State University, and a fellowship at the University of California San Francisco in medical oncology and hematology. Dr. Donovan is certified by the American Board of Medical Oncology and American Board of Internal Medicine. He is a member of the American Medical Association, American College of Physicians, American Society of Internal Medicine, American Society of Clinical Oncology and Arizona Clinical Oncology Society, where he currently President. Dr. Donovan has special interests in breast cancer, lymphomas, and melanoma.

• Language(s): English

• College: University of Colorado
• Medical School: Midwestern University
• Internship: Rush University Medical Center
• Residency: Rush University Medical Center
• Fellowship: Baylor University Medical Center
• Board Certification: American Board of Internal Medicine, Medical Oncology, Internal Medicine

Dr. Justin Goldfarb specializes in medical oncology, internal medicine and hematology.

Growing up in suburban Detroit, Dr. Goldfarb followed his true passion to become a hematologist and medical oncologist. A published author on topics including lymphoma and breast cancer, he is double board-certified in medical oncology and internal medicine, and fellowship-trained in hematologic disorders and solid tumors.

Dr. Goldfarb earned a Bachelor’s degree from the University of Colorado at Boulder and holds a medical degree from Midwestern University in Chicago. He completed an internal medicine residency at Rush University Medical Center in Chicago, followed by a medical oncology fellowship at Baylor University Medical Center in Dallas. With academic appointments at Pritzker School of Medicine at the University of Chicago and Midwestern University, Dr. Goldfarb thoroughly enjoys teaching and mentoring medical students.

• Language(s): English

• College: City College of New York
• Medical School: State University of New York at Buffalo
• Internship: University of Chicago Hospital and Clinics
• Residency: University of Chicago Hospital and Clinics
• Fellowship: Memorial Sloan-Kettering Cancer Center
• Board Certification: American Board of Internal Medicine, Medical Oncology, Internal Medicine

Dr. Michael S. Gordon specializes in medical oncology and hematology, and his principle interests have been in the development of new cancer therapies with a focus on targeted therapies as well as drugs that affect angiogenesis (tumor blood vessel supply). His disease focuses include kidney cancer, melanoma, prostate cancer, gastrointestinal stromal tumor (GIST) and ovarian cancer. In 2014, Dr. Gordon was named medical director for the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute.

Dr. Gordon joined Arizona Center for Cancer Care in 2013 when his team at Pinnacle Oncology Hematology partnered with them. He first came to Arizona to become the associate dean for research for the Phoenix campus of the University of Arizona College of Medicine and subsequently founded the Arizona Cancer Center’s Drug Development Program in Scottsdale. Dr. Gordon led the Arizona Cancer Center’s activities in the greater-Phoenix area until November 2005 when the Drug Development Program was converted to Pinnacle Oncology Hematology as a free-standing research practice. Pinnacle Oncology joined Arizona Center for Cancer Care in 2013. Currently, Dr. Gordon also serves as an associate professor of clinical medicine at the University of Arizona College of Medicine.

Dr. Gordon received his Bachelor of Science degree in Biomedical Sciences from the Sophie Davis School for Biomedical Education at the City College of New York and his Medical degree from the State University of New York at Buffalo School of Medicine. Following his graduation from medical school, Dr. Gordon performed his internship and residency in Internal Medicine at the University of Chicago Hospitals and Clinics. After completing his fellowship in Hematology/Oncology at Memorial Sloan-Kettering Cancer Center in 1991, he accepted a position at the Indiana University School of Medicine as a faculty member in the Section of Hematology/Oncology. During nine years on the faculty at Indiana University, Dr. Gordon played integral roles in the development of the Indiana University Cancer Center’s Biologics and Developmental Therapeutics Program, the Leukemia Program, Clinical Research Office, and the Scientific Review Committee.

Dr. Gordon is a member of the American College of Physicians, American Society of Clinical Oncology, International Society of Experimental Hematology, American Society of Hematology, American Association for Cancer Research and New York Academy of Science. He has been awarded the American Cancer Society’s Clinical Oncology Career Development Award and has served as co-editor of Yearbook of Oncology.

Biography

Language(s): English

College: University of Minnesota, Twin Cities

Medical School: West Virginia University School of Medicine

Internship: University of Texas Health Science Center San Antonio

Residency: University of Texas Health Science Center San Antonio

Fellowship: University of Texas Health Science Center San Antonio

Board Certification: American Board of Internal Medicine, Hematology and Medical Oncology

Dr. Stephanie Lindauer specializes in Medical Oncology, Hematology and Internal Medicine. Her clinical interests include breast cancer and benign breast disease, gastrointestinal cancer and cancer survivorship.

Dr. Lindauer joined Arizona Center for Cancer Care in 2018. She received her Bachelor of Science degree in Biology from the University of Minnesota, Twin Cities Honors Program. She completed medical school at West Virginia University School of Medicine. Dr. Lindauer completed both her internship and residency in Internal Medicine at University of Texas Health Science Center in San Antonio. She completed her fellowship in Hematology/Oncology at the University of Texas Health Science Center in San Antonio; training at their NCI-designated cancer center with exposure to a variety of cancers as well as clinical trials.

Dr. Lindauer has held a variety of leadership roles. She was Chief Resident of the Department of Internal Medicine, serving an additional year after completing her residency in San Antonio. She also served as Chief Fellow during her last year of fellowship in San Antonio. Dr. Lindauer has several abstracts and poster presentations at local and national meetings, including ASCO Survivorship Symposium, ASCO Quality Care Symposium and ASH Hematologic Malignancies. She is passionate about engagement within her community and has presented at Updates for the San Antonio Community from the San Antonio Breast Cancer Symposium in 2017.

Dr. Lindauer was drawn to the field of oncology from a young age, having seen the effects of cancer in loved ones. She feels honored to be able to fulfill such an important role now and strives for compassion and empathy with all her patients.

Dr. Lindauer is a member of the American Society of Clinical Oncology and American Society of Hematology. She enjoys spending time with her husband and her chocolate lab.

• Language(s): English

• College: University of Michigan
• Medical School: Ohio State University
• Internship: Ohio State University
• Residency: Ohio State University
• Fellowship: Duke University
• Board Certification: American Board of Internal Medicine: Medical Oncology, Internal Medicine

Dr. David S. Mendelson specializes in medical oncology and hematology. His clinical interests include the management of patients with hematologic disorders, prostate cancer and lung cancer; with a particular interest in drug development.

Dr. Mendelson joined Arizona Center for Cancer Care in 2013, when his team at Pinnacle Oncology Hematology partnered with the practice. He received his medical degree and completed internal medicine residency at Ohio State University. After completing his fellowship training in medical oncology and hematology at Duke University, he joined the faculty as a clinical instructor and research fellow in immuno-hematology. During his 30-plus year career in the Valley, Dr. Mendelson has served as chairman of the Department of Medicine and executive committee member at Thunderbird Samaritan (Banner) Medical Center. In 2001, he joined the University of Arizona as an Assistant Professor of Clinical Medicine working with Dr. Gordon to create the Drug Development Program of the Arizona Cancer Center, Greater Phoenix Area. With the development of Pinnacle Oncology Hematology in 2005, Dr. Mendelson continued his interests in drug development.

Dr. Mendelson has been a consultant to pharmaceutical industry drug development and for the National Cancer Institute’s drug assessment programs.